A successful joint collaboration between researchers at the Hebrew university of Jerusalem and the startup company TyrNovo may lead to a potential treatment of brain diseases. The researchers found that TyrNovo’s novel and unique compound, named NT219, selectively inhibits the process of…
New compound for slowing the aging process can lead to novel treatments for brain diseases
No comments:
Post a Comment